awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38666253-F4748F5F-9CB3-4062-B805-1C8A77AD348F
Q38666253-F4748F5F-9CB3-4062-B805-1C8A77AD348F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38666253-F4748F5F-9CB3-4062-B805-1C8A77AD348F
The future of immune checkpoint cancer therapy after PD-1 and CTLA-4.
P2860
Q38666253-F4748F5F-9CB3-4062-B805-1C8A77AD348F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38666253-F4748F5F-9CB3-4062-B805-1C8A77AD348F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32f5ccd398f36a4837fb9519fbfc3fc41a331cf3
P2860
Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.